Avaccine administration law was adopted by the National People’s Congress (NPC) of China, the top legislative body of the country, on June 29, marking the beginning of improved vaccine administration. The law will go into effect on December 1.
Whole-process supervision
As biological products used on healthy people, mostly infants, vaccines pertain to public health, and hence to public safety and national security, said Jiao Hong, head of the National Medical Products Administration (NMPA), at a press conference on June 29 at the Great Hall of the People to announce the adoption of the law.
“Vaccine supervision will cover the whole process, from vaccine development, production and distribution to vaccination,” she said, noting that in light of their unique characteristics, vaccines should be subject to the strictest regulation.
The law…